| abstract |
The present application provides isotopically enriched arylsulfonamides useful in the modulation of CCR3 activity, for example, isotopically enriched arylsulfonamides of formula (I), and pharmaceutical compositions thereof. Also provided herein are methods of use thereof for the treatment, prevention or amelioration of one or more symptoms of a CCR3-mediated disease, disorder or disorder: (I) |